<!-- markdownlint-disable-file -->
# Final Research Completeness Review

## Review Metadata

- Date: 2026-08-20
- Reviewer Role: Independent research verification subagent
- Scope: completeness and factual-consistency review only; no new topic research
- Target document:
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md
- Cross-check documents:
  - prd-v0.1.md
  - .copilot-tracking/research/subagents/2026-08-20/pubmed-eutilities-research.md
  - .copilot-tracking/research/subagents/2026-08-20/clinicaltrials-api-research.md
  - .copilot-tracking/research/subagents/2026-08-20/scholarly-discovery-alternatives-research.md
  - .copilot-tracking/research/subagents/2026-08-20/citation-existence-verification-research.md
  - .copilot-tracking/research/subagents/2026-08-20/integration-alternatives-analysis.md
  - .copilot-tracking/research/subagents/2026-08-20/prd-local-assumptions-research.md

## Overall Verdict

- Verdict: PASS (non-blocking issues only)
- Blocking research gap: Not identified
- Confidence: High (based on direct document cross-check + source-evidence consistency)

## Checkpoint-by-Checkpoint Assessment

### 1) 用户四项问题是否逐一、直接、完整回答

Assessment: PASS (with traceability improvement opportunity)

Evidence:
- 四项任务在主文档中明确列出：
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:23-29
- 对应内容在后续章节均有实质展开：
  - PubMed: 同文档 API and Schema / Technical Scenarios（PubMed）
  - CT.gov: 同文档 API and Schema / Technical Scenarios（ClinicalTrials.gov）
  - Scholar/OpenAlex/Europe PMC: 同文档 Discovery source comparison
  - PMID/NCT existence: 同文档 Strict existence verification + acceptance matrix

Note:
- 已回答完整，但不是“Q1/Q2/Q3/Q4”显式映射格式；机器复核可读性可再增强。

### 2) 是否清楚区分官方规范、端点实测、项目设计选择和仍是假设

Assessment: PASS

Evidence:
- 主文档有三分法标签和“design choice”分层：
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:88-96
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:102-109
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:478-499
- 子文档也采用“官方规范已验证/端点实测已验证/条件性”标签：
  - .copilot-tracking/research/subagents/2026-08-20/pubmed-eutilities-research.md
  - .copilot-tracking/research/subagents/2026-08-20/clinicaltrials-api-research.md
  - .copilot-tracking/research/subagents/2026-08-20/scholarly-discovery-alternatives-research.md

### 3) PubMed 字段、速率、retmax/9999 vs 10000、时间过滤有无过强或错误表述

Assessment: PASS

Evidence:
- 无 key 3 rps、有 key 10 rps 的口径一致且来源为 NCBI 文档：
  - .copilot-tracking/research/subagents/2026-08-20/pubmed-eutilities-research.md:67-76
- 10,000（文档）与 9,999（实测）被明确分开陈述，未混淆：
  - .copilot-tracking/research/subagents/2026-08-20/pubmed-eutilities-research.md:79-118
- 时间过滤参数与 PubMed 字段语义区分充分：
  - .copilot-tracking/research/subagents/2026-08-20/pubmed-eutilities-research.md:119-146

Risk note:
- 主文档与子文档都正确把 9,999 作为“当前实测边界”，并保留“未来可能变化”的谨慎表述。

### 4) ClinicalTrials.gov v2、查询参数、无独立 target 字段、phase/status 路径和缺失语义是否准确

Assessment: PASS

Evidence:
- v2 base 与主要端点表述一致：
  - .copilot-tracking/research/subagents/2026-08-20/clinicaltrials-api-research.md:8-18, 28-36
- 参数语义与高级语法说明一致：
  - .copilot-tracking/research/subagents/2026-08-20/clinicaltrials-api-research.md:75-94
- “无独立分子靶点字段”结论具备公开 schema 依据并保留条件性标签：
  - .copilot-tracking/research/subagents/2026-08-20/clinicaltrials-api-research.md:96-110
- phase/status 路径与缺失语义（尤其 observational phase 缺失）准确：
  - .copilot-tracking/research/subagents/2026-08-20/clinicaltrials-api-research.md:112-141

### 5) Google Scholar 官方 API 结论审慎性；OpenAlex/Europe PMC 覆盖比较边界

Assessment: PASS

Evidence:
- Scholar 结论使用“未发现公开受支持 API”而非绝对化否定，并说明证据边界：
  - .copilot-tracking/research/subagents/2026-08-20/scholarly-discovery-alternatives-research.md:34-64
- OpenAlex/Europe PMC 的覆盖和能力比较包含官方来源与“非完全等价”边界：
  - .copilot-tracking/research/subagents/2026-08-20/scholarly-discovery-alternatives-research.md:238-299

### 6) PMID/NCT existence 算法：EFetch coercion、query.id 误命中、HTTP/语义状态区分

Assessment: PASS

Evidence:
- 明确记录 EFetch coercion 风险（ABC123 -> 123）并禁止将 EFetch 用于 existence 判据：
  - .copilot-tracking/research/subagents/2026-08-20/citation-existence-verification-research.md:80-99
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:425-432
- 明确记录 query.id 误命中风险并限制为不可用于严格 NCT existence：
  - .copilot-tracking/research/subagents/2026-08-20/citation-existence-verification-research.md:116-121
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:449-456
- HTTP 与语义状态区分清晰（200 不等于 exists）：
  - .copilot-tracking/research/subagents/2026-08-20/citation-existence-verification-research.md:150-151
  - .copilot-tracking/research/subagents/2026-08-20/citation-existence-verification-research.md:248-285

### 7) 推荐 B+2：替代方案分析、实施影响、验收标准

Assessment: PASS

Evidence:
- A/B/C 与 1/2/3 均有对比、取舍与拒绝理由：
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:461-476
  - .copilot-tracking/research/subagents/2026-08-20/integration-alternatives-analysis.md
- 实施影响（模块边界、数据模型、降级规则、实施顺序）齐全：
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:500-595
- 验收标准清单明确且可测试：
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:596-613

### 8) 关键工作区引用存在性与行号大体准确；外部链接一手来源

Assessment: PASS (sampling-based)

Evidence:
- 文档行数均覆盖主要引用范围（无明显越界）：
  - prd-v0.1.md 总行数 583
  - 主研究文档总行数 649
  - 子研究文档行数均与引用范围匹配
- 抽样核对主研究文档中 prd 引用（165-194, 211-248, 373-375, 510-523, 549-555）与原文语义一致。
- 外部链接以官方一手来源为主（NCBI、ClinicalTrials.gov、Google 官方页面、OpenAlex 官方帮助文档、Europe PMC 官方文档）。

Boundary:
- 本项为抽样复核，不是逐链接在线可达性扫描。

### 9) 是否仍有阻塞性研究缺口

Assessment: PASS (no blocking gap)

Evidence:
- 主文档将未决项明确列为非阻塞（如 NCT alias 301、缓存 TTL、召回评测等）。
  - .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:46-63, 646-649
- 这些项属于实施/优化阶段验证，不阻断当前方案进入实现规划。

## Findings By Severity

### Critical

- None.

### High

- None.

### Medium

1. Four-question directness can be made machine-auditable.
- Issue: 主文档虽然完整回答了四项问题，但缺少“问题-答案一一映射表”作为显式索引。
- Impact: 后续自动化复核与需求追踪可读性下降。
- Evidence: .copilot-tracking/research/2026-08-20/drug-target-scout-technical-assumptions-research.md:23-29（问题列出），答案分散在后续章节。
- Recommendation: 增加一节“Question-to-Answer Map”并指向精确段落。

### Low

1. Alias 301 handling remains unvalidated by live sample.
- Issue: `/studies/{nctId}` 的 301 alias 行为是规范声明，未在本轮实测样本覆盖。
- Impact: 对 alias 输入的边缘路径仍需合同测试确认。
- Evidence: .copilot-tracking/research/subagents/2026-08-20/citation-existence-verification-research.md:160, 358

2. “Line-number accuracy” is credible but currently sampling-based.
- Issue: 本次复核对工作区引用做了抽样一致性校验，未做逐条全量验证。
- Impact: 极低，主要是审计严谨度表达问题。
- Recommendation: 若进入审计提交阶段，可增加自动脚本做全量 path/line existence lint。

## Must-Fix Items

- None (no blocker found).

## Optional Improvements

1. 在主研究文档新增“Q1~Q4 显式对照表”，提升需求可追溯性。
2. 在实施前补一条 alias 301 合同测试（NCT alias 正样本）。
3. 增加自动化引用 lint（路径存在 + 行号范围）以支撑后续审计。

## Final Decision

- PASS
- Ready for implementation planning with non-blocking refinements above.
